# EDGAR Filing Document

**Accession Number:** 0001868640
**File Stem:** 0001493152-26-008128
**Filing Date:** 2026-2
**Character Count:** 23900
**Document Hash:** 65893f1a5cbeee442b4d59e84a28d5b1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-008128.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0001493152-26-008128

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260225

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260226

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Roadzen Inc.
- **CENTRAL INDEX KEY:** 0001868640
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 981600102
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41094
- **FILM NUMBER:** 26681766

**BUSINESS ADDRESS:**
- **STREET 1:** 111 ANZA BLVD., SUITE 109
- **CITY:** BURLINGAME
- **STATE:** CA
- **ZIP:** 94010
- **BUSINESS PHONE:** 650-414-3530

**MAIL ADDRESS:**
- **STREET 1:** 111 ANZA BLVD., SUITE 109
- **CITY:** BURLINGAME
- **STATE:** CA
- **ZIP:** 94010

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vahanna Tech Edge Acquisition I Corp.
- **DATE OF NAME CHANGE:** 20210621

?xml version='1.0' encoding='ASCII'?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION** **WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): February 25, 2026**

**ROADZEN INC.**

**(Exact name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **British Virgin Islands** | **001-41094** | **98-1600102** |
| **(State or Other Jurisdiction<br> of Incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer<br> Identification No.)** |

---

---

| | |
|:---|:---|
| **111 Anza Blvd**<br> **Suite 109** |  |
| **Burlingame, California** | **94010** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (**347) 745-6448**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Ordinary Shares, par value $0.0001 per share | RDZN | The Nasdaq Stock Market LLC |
| Warrants, each warrant exercisable for one ordinary share, each at an exercise price of $11.50 per share | RDZNW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry into a Material Definitive Agreement.**

On February 25, 2026, Roadzen Inc. (the "Company") entered into a Second Amendment to Securities Purchase Agreement and Junior Convertible Note (the "Second Amendment"), which amended certain of the terms of (i) that certain Securities Purchase Agreement, dated as of November 20, 2025 (the "SPA"), entered into between the Company and an institutional investor (the "Investor"), and (ii) the junior convertible notes issued to the Investor in November 2025 (as previously amended, the "November Notes") pursuant to the terms of the SPA, as described in the Current Report on Form 8-K filed by the Company on November 20, 2025. Certain terms of the November Notes were previously amended pursuant to an Amendment to Securities Purchase Agreement Junior Convertible Note entered into between the Company and the Investor on January 20, 2026, as described in the Current Report on Form 8-K filed by the Company on that date. Among other things, the Second Amendment (i) amends the November Notes to change the first and second "Installment Dates" under the November Notes to April 21, 2026 and May 21, 2026, respectively, and (ii) amends the SPA to grant the Investor a right to participate in certain financings that may be effected by the Company prior to June 20, 2026, subject to certain conditions and limitations.

The foregoing descriptions of the terms and conditions of the Second Amendment do not purport to be complete and are qualified in their entireties by the full text of Second Amendment, which is filed as exhibit 10.1 to this Current Report on Form 8-K.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit Number** | **Description of Exhibit** |
| 10.1 | [Second Amendment to Securities Purchase Agreement and Junior Convertible Note, dated February 25, 2026.](ex10-1.htm) |
| 104 | Cover page interactive data file (embedded within the Inline XBRL document). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **ROADZEN INC.** | **ROADZEN INC.** |
| Date: | February 26, 2026 | By: | */s/ Jean-Noël Gallardo* |
|  |  | Name:<br> Title: | Jean-Noël Gallardo<br> Chief Financial Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**SECOND AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND JUNIOR CONVERTIBLE NOTE**

This SECOND AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND JUNIOR CONVERTIBLE NOTE ("***Amendment***") is dated as of February 25, 2026, and is entered into by and among Roadzen Inc., a BVI business company limited by shares incorporated with limited liability in the British Virgin Islands (the "***Company***"), and _______________ (the "***Purchaser***"). The Company and the Purchaser are hereinafter sometimes collectively referred to as the "***Parties***" and each individually as a "***Party***".

**RECITALS:**

**WHEREAS**, the Company and the Purchaser are party to (i) that certain Securities Purchase Agreement dated November 20, 2025 (as amended on January 20, 2026, the "***SPA***"), and (ii) that certain Junior Convertible issued by the Company to the Purchaser pursuant to the SPA (as amended on January 20, 2026, the "***Note***");

**WHEREAS**, the Company and the Purchaser desire to amend certain terms and conditions of the Note as provided herein;

**NOW, THEREFORE**, in consideration of the mutual conditions and agreements set forth in this Amendment, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>**Definitions**</u>. Capitalized terms used in this Amendment but not otherwise defined herein have the meanings given such terms in the SPA or the Note, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>**Amendments and Agreements regarding the Note**</u>**.**

(a) Section
 31(r) of the Note is amended and restated as follows: "**Installment Date** "
 means (A) with respect to the first such date, April 21, 2026, (B) with respect to the second
 such date, May 21, 2026, and (C) with respect to all such dates subsequent thereto, the date
 that is three (3) calendar months from the previous Installment Date until the Maturity Date;"

(b) A
 new Section 4(aa) is added to the SPA as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(aa) PARTICIPATION RIGHT

&nbsp;&nbsp;&nbsp;&nbsp;i. <u>Grant</u>.
 The Company grants to the Holder a right (the "**Participation Right**") to
 participate in any Subsequent Financing (as defined below) by purchasing up to the greater
 of (x) thirty-five percent (35%) of the aggregate principal amount, aggregate liquidation
 preference, or gross proceeds (as applicable) of the credit financing, note financing, equity
 securities, or other securities issued in such Subsequent Financing or (y) such percentage
 of aggregate principal amount, aggregate liquidation preference, or gross proceeds (as applicable)
 of the credit financing, note financing, equity securities, or other securities issued in
 such Subsequent Financing that is not subscribed for (for any reason) by other investors
 (collectively, the "**Participation Amount** "), on the same price and economic
 terms (including any discounts, warrant coverage, original issue discount, or other economic
 enhancements) as offered to the other banks, financial institutions or investors in such
 Subsequent Financing.

&nbsp;&nbsp;&nbsp;&nbsp;ii. <u>Subsequent Financings</u>. For purposes hereof, "**Subsequent Financing**" means any
 issuance or sale by the Company or any of its Subsidiaries of equity securities, preferred
 equity, convertible securities, or indebtedness (including convertible or exchangeable indebtedness),
 whether in a private placement, registered offering, or otherwise, in one or a series of
 related transactions. Subsequent Financing shall not include (x) issuances of Excluded Securities
 (as defined in the Notes) and (y) issuances by Subsidiaries of securities other than (1)
 Ordinary Shares and/or (2) securities that are exercisable or exchangeable for or convertible
 into Ordinary Shares.

&nbsp;&nbsp;&nbsp;&nbsp;iii. <u>Notice; Election</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. At
 least three (3) Trading Day prior to any proposed or intended Subsequent Financing, the Company
 shall deliver to the Holder a written notice (each such notice, a "**Pre-Notice** "),
 which Pre-Notice shall not contain any information (including, without limitation, material,
 non-public information) other than: (A) if the proposed Offer Notice (as defined below) constitutes
 or contains material, non-public information, a statement asking whether the Holder is willing
 to accept material non-public information or (B) if the proposed Offer Notice does not constitute
 or contain material, non-public information, (x) a statement that the Company proposes or
 intends to effect a Subsequent Financing, (y) a statement that the statement in clause (x)
 above does not constitute material, non-public information and (z) a statement informing
 the Holder that it is entitled to receive an Offer Notice (as defined below) with respect
 to such Subsequent Financing upon its written request. Upon the written request of a the
 Holder within one (1) Trading Day after the Company's delivery to the Holder of such
 Pre-Notice, and only upon a written request by the Holder, the Company shall promptly, but
 no later than one (1) Trading Day after such request, deliver to the Holder an irrevocable
 written notice (the "**Offer Notice**") of any proposed or intended issuance
 or sale or exchange (the "**Offer**") of the securities being offered (the
 "**Offered Securities**") in a Subsequent Financing, which Offer Notice shall
 (A) identify and describe the Offered Securities, (B) describe the price and other terms
 upon which they are to be issued, sold or exchanged, and the number or amount of the Offered
 Securities to be issued, sold or exchanged, (C) identify the Persons (if known) to which
 or with which the Offered Securities are to be offered, issued, sold or exchanged and (D)
 offer to issue and sell to or exchange with the Holder in accordance with the terms of the
 Offer the Holder's portion of 35% of the Offered Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Notwithstanding
 the provisions of Section 4(aa)(iii)(a), if the Offered Securities consist of Ordinary Shares
 and or warrants to purchase Ordinary Shares only, then the Company shall deliver the Offer
 Notice to the Holder between the time period of 4:00 pm (New York City time) and 6:00 pm
 (New York City time) on the Trading Day immediately prior to the Trading Day of the expected
 announcement of the Subsequent Financing (or, if the Trading Day of the expected announcement
 of the Subsequent Financing is the first Trading Day following a holiday or a weekend (including
 a holiday weekend), between the time period of 4:00 pm (New York City time) on the Trading
 Day immediately prior to such holiday or weekend and 2:00 pm (New York City time) on the
 day immediately prior to the Trading Day of the expected announcement of the Subsequent Financing).

&nbsp;&nbsp;&nbsp;&nbsp;iv. <u>Exercise</u>.
 The Holder may exercise the Participation Right at any time following receipt of the Offer
 Notice but prior to 7:00am ET on the date of the consummation of the proposed Subsequent
 Financing by delivering written notice to the Company. The Company shall allocate to the
 Holder the full Participation Amount. If the financing is oversubscribed, the Participation
 Amount shall be reserved for the Holder prior to allocating securities to any other investor.

&nbsp;&nbsp;&nbsp;&nbsp;v. <u>Subsequent Financing Documents</u>. The Company and the Holder agree that if the Holder elects to participate
 in the Offer, the transaction documents for the Subsequent Financing with respect to such
 Offer shall not include any term or provision whereby the Holder shall be required to agree
 to any restrictions on trading as to any securities of the Company or be required to consent
 to any amendment to or termination of, or grant any waiver, release or the like under or
 in connection with, any agreement previously entered into with the Company or any instrument
 received from the Company.

&nbsp;&nbsp;&nbsp;&nbsp;vi. <u>Announcement</u>.
 Notwithstanding anything to the contrary in this Section 4(aa) and unless otherwise agreed
 to by the Holder, the Company shall either confirm in writing to the Holder that the transaction
 with respect to the Subsequent Financing has been abandoned or shall publicly disclose its
 intention to issue the Offered Securities, in either case, in such a manner such that the
 Holder will not be in possession of any material, non-public information, by the fifth (5<sup>th</sup>)
 Business Day following delivery of the Offer Notice. If by such fifth (5<sup>th</sup>) Business
 Day, no public disclosure regarding a transaction with respect to the Offered Securities
 has been made, and no notice regarding the abandonment of such transaction has been received
 by the Holder, such transaction shall be deemed to have been abandoned and the Holder shall
 not be in possession of any material, non-public information with respect to the Company
 or any of its Subsidiaries. Should the Company decide to pursue such transaction with respect
 to the Offered Securities, the Company shall provide the Holder with another Pre-Notice and
 the Holder will again have the right of participation set forth in this Section 4(aa).

&nbsp;&nbsp;&nbsp;&nbsp;vii. <u>Remedy.</u> In the event that the Company fails to notify the Holder of a Subsequent Financing in
 accordance with this Section 4(aa) or otherwise fails to comply with any of the provisions
 of this Section 4(aa), then the Holder shall have the right, by delivering a written notice
 to the Company, during the thirty (30) day calendar period commencing on the date of the
 first public announcement of the Subsequent Financing to, at the Holder's option, participate
 in the Subsequent Financing or subscribe for the securities or debt offered in such Subsequent
 Financing in a separate transaction on substantially equivalent terms as that of the Subsequent
 Financing. This paragraph shall not be an exclusive remedy for the Company's failure
 to comply with this Section 4(aa).

&nbsp;&nbsp;&nbsp;&nbsp;viii. <u>Termination</u>.
 The Participation Right shall terminate on June 20, 2027, except that the provisions of Section
 4(aa)(vii) shall survive with respect to any Subsequent Financing consummated prior to the
 June 20, 2027, in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;ix. <u>Survival; Transferability</u>. The Participation Right shall survive any repayment, redemption or conversion
 of the Notes prior to such termination date. The Participation Right may be transferred by
 the Holder together with the Notes (but not separately therefrom) without the consent of
 any other party hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>**Conditions to Effectiveness**</u>**.** The effectiveness of this Amendment is subject to the prior or concurrent consummation of each of the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Signature</u>. Each Party shall have delivered an executed counterpart of its signature page to this Amendment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>No Event of Default</u>. After giving effect to this Amendment and the transactions contemplated hereby, no Event of Default shall have occurred and be continuing; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **<u>Reserved</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5. <u>**Affirmations**</u>. The Company acknowledges and agrees:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the Transaction Documents are legal, valid, binding and enforceable against the Company accordance with their respective terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the Company's obligations under the Note and the other Transaction Documents are not subject to any setoff, deduction, claim, counterclaim or defenses of any kind or character whatsoever; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the Purchaser has fully and timely performed all of its obligations and duties in compliance with the Transaction Documents and applicable law, and has acted reasonably, in good faith and appropriately under the circumstances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <u>**Severability**</u>**.** The illegality or unenforceability of any provision of this Amendment shall not in any way affect or impair the legality or enforceability of the remaining provisions of this Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. <u>**References**</u>**.** Any reference to the Notes contained in any notice, request, certificate, or other document executed concurrently with or after the execution and delivery of this Amendment shall be deemed to include this Amendment unless the context shall otherwise require. Reference in any of this Amendment, the Notes or any other Transaction Document to the Notes shall be a reference to the Notes as amended hereby and as further amended, modified, restated, supplemented or extended from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. <u>**Counterparts**</u>**.** This Amendment may be executed in any number of counterparts and by the different parties hereto on separate counterparts and each such counterpart shall be deemed to be an original, but all such counterparts shall together constitute but one and the same agreement. Receipt by telecopy of any executed signature page to this Amendment shall constitute effective delivery of such signature page. This Amendment to the extent signed and delivered by means of a facsimile machine or other electronic transmission (including "pdf"), shall be treated in all manner and respects and for all purposes as an original agreement or amendment and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto shall raise the use of a facsimile machine or other electronic transmission to deliver a signature or the fact that any signature or agreement or amendment was transmitted or communicated through the use of a facsimile machine or other electronic transmission as a defense to the formation or enforceability of a contract and each such party forever waives any such defense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>**Captions**</u>**.** Section captions used in this Amendment are for convenience only and shall not affect the construction of this Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>**Ratification**</u>**.** The terms and provisions set forth in this Amendment shall modify and supersede all inconsistent terms and provisions of the Notes and shall not be deemed to be a consent to the modification or waiver of any other term or condition of the Notes. Except as expressly modified and superseded by this Amendment, the terms and provisions of the Notes and the other Transaction Documents are ratified and confirmed and shall continue in full force and effect. This Amendment constitutes the entire agreement, and supersedes all prior understandings and agreements, among the parties relating to the subject matter hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. <u>**Governing Law**</u>. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **<u>Disclosure/8-K obligation</u>**. The Company will disclose the material terms of this Amendment and the transactions contemplated hereby in a Current Report on Form 8-K, and attaching this Amendment as an exhibit thereto, by not later than 8:30 a.m. on the Trading Day immediately following the execution of this Amendment (the "***Form 8-K***"). Upon the filing of such Form 8-K, the Company represents to the Holder that it shall have publicly disclosed all "material, non-public information" delivered to the Holder by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents.

[*Signature Page Follows*]

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their respective duly authorized officers on the date first written above.

---

| | |
|:---|:---|
| Roadzen Inc. | Roadzen Inc. |
| By: | /s/ Rohan Malhotra |
| Name: | Rohan Malhotra |
| Title: | CEO |
| PURCHASER | PURCHASER |
| By: |  |
| Name: |  |
| Title: |  |

---

Signature Page to Second Amendment to Securities

Purchase Agreement and Note